Page last updated: 2024-11-08

dimethylphenylpiperazinium iodide and Hirschsprung Disease

dimethylphenylpiperazinium iodide has been researched along with Hirschsprung Disease in 2 studies

Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.

Hirschsprung Disease: Congenital MEGACOLON resulting from the absence of ganglion cells (aganglionosis) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wood, JD1
Brann, LR1
Hanani, M1
Lernau, OZ1
Zamir, O1
Nissan, S1

Other Studies

2 other studies available for dimethylphenylpiperazinium iodide and Hirschsprung Disease

ArticleYear
Pharmacological analysis of rebound excitation in large intestine of piebald mouse model for Hirschsprung's disease.
    Digestive diseases and sciences, 1986, Volume: 31, Issue:7

    Topics: Animals; Atropine; Dimethylphenylpiperazinium Iodide; Guanethidine; Hirschsprung Disease; Indomethac

1986
Nerve mediated responses to drugs and electrical stimulation in aganglionic muscle segments in Hirschsprung's disease.
    Journal of pediatric surgery, 1986, Volume: 21, Issue:10

    Topics: Child; Dimethylphenylpiperazinium Iodide; Electric Stimulation; Electrophysiology; Hirschsprung Dise

1986